Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Marek

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Neurology|September 7, 2007
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8W C Nichols, V E Elsaesser, N Pankratz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Alpha-synuclein and familial Parkinson's diseaseNathan Pankratz, William C Nichols, Veronika E Elsaesser, et al.
Neuroscience Letters|September 26, 2006
Mutations in DJ-1 are rare in familial Parkinson diseaseNathan Pankratz, Michael W Pauciulo, Veronika E Elsaesser, et al.
Neurology|November 7, 2008
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onsetW C Nichols, N Pankratz, D K Marek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Individuals with Early Alzheimer's Disease: Amyloid Imaging Positron Emission Tomography and Safety Results from a Phase 2 StudyC H van Dyck, C Sadowsky, G Le Prince Leterme, et al.
Neurology|May 29, 2003
Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysisH D Rosas, W J Koroshetz, Y I Chen, et al.
NPJ Parkinson'S Disease|February 1, 2019
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderL M Chahine, A Iranzo, A Fernández-Arcos, et al.
Translational Psychiatry|September 17, 2014
Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injuryE M Mitsis, S Riggio, L Kostakoglu, et al.
Neurology|January 26, 2005
The role of radiotracer imaging in Parkinson diseaseB Ravina, D Eidelberg, J E Ahlskog, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Neurology|September 7, 2007
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8W C Nichols, V E Elsaesser, N Pankratz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Alpha-synuclein and familial Parkinson's diseaseNathan Pankratz, William C Nichols, Veronika E Elsaesser, et al.
Neuroscience Letters|September 26, 2006
Mutations in DJ-1 are rare in familial Parkinson diseaseNathan Pankratz, Michael W Pauciulo, Veronika E Elsaesser, et al.
Neurology|November 7, 2008
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onsetW C Nichols, N Pankratz, D K Marek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Individuals with Early Alzheimer's Disease: Amyloid Imaging Positron Emission Tomography and Safety Results from a Phase 2 StudyC H van Dyck, C Sadowsky, G Le Prince Leterme, et al.
Neurology|May 29, 2003
Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysisH D Rosas, W J Koroshetz, Y I Chen, et al.
NPJ Parkinson'S Disease|February 1, 2019
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderL M Chahine, A Iranzo, A Fernández-Arcos, et al.
Translational Psychiatry|September 17, 2014
Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injuryE M Mitsis, S Riggio, L Kostakoglu, et al.
Neurology|January 26, 2005
The role of radiotracer imaging in Parkinson diseaseB Ravina, D Eidelberg, J E Ahlskog, et al.
Pageof 12